This week results from two clinical trial studies were released by the American Society of Clinical Oncology and published in the New England Journal of Medicine, announcing that Avastin (also called bevacizumab), a chemotherapy drug used for other types of cancer, could help women by slowing down the progression of ovarian cancer.
Results are already controversial in the medical communities, but women with advanced cases of ovarian cancer can add about four months of time to the period between the cancer being considered under control to its getting worse, or progressing, according to this new report.
Click here to read the entire article.
I really appreciate this post. I’ve been looking everywhere for this! Thank goodness I found it on Bing. You’ve made my day! Thx again!